EARNINGS PER SHARE (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Net Income for Earnings Per Share Calculations:
Income from continuing operations, net of tax	$	366.4	$	254.2	$	693.1	$	556.4
Net loss attributable to noncontrolling interests	(1.3)		(1.6)		(2.2)		(1.6)
Income from continuing operations attributable to Edwards Lifesciences Corporation	367.7		255.8		695.3		558.0
(Loss) income from discontinued operations	(1.4)		51.3		22.9		89.6
Net income attributable to Edwards Lifesciences Corporation	$	366.3	$	307.1	$	718.2	$	647.6
Weighted Average Shares:
Basic weighted-average shares outstanding	602.1		606.9		601.8		607.2
Dilutive effect of stock plans	2.2		3.4		2.4		3.4
Dilutive weighted-average shares outstanding	604.3		610.3		604.2		610.6
Earnings per Share:
Basic:
Continuing operations	$	0.61	$	0.42	$	1.15	$	0.92
Discontinued operations	—		0.09		0.04		0.15
Basic earnings per share	$	0.61	$	0.51	$	1.19	$	1.07
Diluted:
Continuing operations	$	0.61	$	0.42	$	1.15	$	0.91
Discontinued operations	—		0.08		0.04		0.15
Diluted earnings per share	$	0.61	$	0.50	$	1.19	$	1.06